Elevated circulating magnesium levels in patients with Parkinson's disease: a meta-analysis.

作者: Xin Jin , Ming-Yan Liu , Dong-Fang Zhang , Hua Gao , Min-Jie Wei

DOI: 10.2147/NDT.S186209

关键词:

摘要: Background The association between circulating magnesium (Mg) and Parkinson's disease (PD) remains ambiguous controversial. Thus, a meta-analysis was conducted to evaluate the Mg levels in PD patients clarify whether high should be considered as potential risk factor for PD. Methods In this study, 17 case-control published studies were selected our by searching electronic databases of Web Science, PubMed, China National Knowledge Infrastructure (CNKI) before June 1, 2018. Overall, 848 cases 784 healthy controls (HC), 1,023 911 HC, 180 144 HC met inclusion criteria study serum, peripheral blood, cerebrospinal fluid (CSF), respectively. Standardized mean difference (SMD) random-effects model 95% CI used assess correlation strength through comparison two groups. Results Meta-analysis showed that serum significantly higher than those individuals (SMD =1.09, =0.52, 1.66). Furthermore, result further confirmed combined analysis whole blood together =0.64, =0.10, 1.19). addition, CSF observed with normal range =0.55, =0.21, 0.88). However, data did not discuss analyze because smaller sample size studies. Conclusion Our findings supported notion increase appears

参考文章(50)
Kristin Gellein, Tore Syversen, Eiliv Steinnes, Tom Ivar Lund Nilsen, Ole Petter Dahl, Sascha Mitrovic, Dusan Duraj, Trond Peder Flaten, Trace elements in serum from patients with Parkinson's disease--a prospective case-control study: the Nord-Trøndelag Health Study (HUNT). Brain Research. ,vol. 1219, pp. 111- 115 ,(2008) , 10.1016/J.BRAINRES.2008.05.002
Silvana S. Bettiol, Tanith C. Rose, Clarissa J. Hughes, Lesley A. Smith, Alcohol Consumption and Parkinson's Disease Risk: A Review of Recent Findings. Journal of Parkinson's disease. ,vol. 5, pp. 425- 442 ,(2015) , 10.3233/JPD-150533
Yutaka Shindo, Ryu Yamanaka, Koji Suzuki, Kohji Hotta, Kotaro Oka, Intracellular magnesium level determines cell viability in the MPP(+) model of Parkinson's disease. Biochimica et Biophysica Acta. ,vol. 1853, pp. 3182- 3191 ,(2015) , 10.1016/J.BBAMCR.2015.08.013
R Swaminathan, Magnesium Metabolism and its Disorders The Clinical biochemist. Reviews / Australian Association of Clinical Biochemists. ,vol. 24, pp. 47- 66 ,(2003)
Yuyang Sun, Pramod Sukumaran, Anne Schaar, Brij B Singh, TRPM7 and its role in neurodegenerative diseases Channels. ,vol. 9, pp. 253- 261 ,(2015) , 10.1080/19336950.2015.1075675
Wolfgang Hoyer, Thomas Antony, Dmitry Cherny, Gudrun Heim, Thomas M. Jovin, Vinod Subramaniam, Dependence of α-synuclein aggregate morphology on solution conditions Journal of Molecular Biology. ,vol. 322, pp. 383- 393 ,(2002) , 10.1016/S0022-2836(02)00775-1
K.M. Powers, T. Smith-Weller, G.M. Franklin, W.T. Longstreth, P.D. Swanson, H. Checkoway, Parkinson's disease risks associated with dietary iron, manganese, and other nutrient intakes. Neurology. ,vol. 60, pp. 1761- 1766 ,(2003) , 10.1212/01.WNL.0000068021.13945.7F
G. Forte, B. Bocca, O. Senofonte, F. Petrucci, L. Brusa, P. Stanzione, S. Zannino, N. Violante, A. Alimonti, G. Sancesario, Trace and major elements in whole blood, serum, cerebrospinal fluid and urine of patients with Parkinson’s disease Journal of Neural Transmission. ,vol. 111, pp. 1031- 1040 ,(2004) , 10.1007/S00702-004-0124-0